RESPIRATORY SYNCYTIAL VIRUS INFECTION
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
RSV pill study halted early: what we know
Disease control TerminatedThis study tested an oral drug called sisunatovir for treating RSV in adults who were not hospitalized but had a high risk of severe illness. Participants took either the drug or a placebo for 5 days. The study was terminated early, so results are limited.
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
RSV drug trial for kids under 5 halted early – only 4 children enrolled
Symptom relief TerminatedThis study tested an oral antiviral drug called obeldesivir in children from birth to under 5 years old who had RSV infection. The goal was to see if the drug is safe and helps reduce symptoms faster. However, the trial was stopped early and only enrolled 4 participants, so the r…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC